April 2021

Editorial Board
Published in issue: April 2021
ii

Copyright
Published in issue: April 2021
iv

Title page
Published in issue: April 2021
v

ORAL COMMUNICATIONS

Special Session: COVID-19, cancer and thrombosis

OC-01 Venous thromboembolic events during the first and second waves of Covid-19 in breast cancer patients treated in an outpatient day hospital
• J. Illarramendi,
• J.L. Modesto,
• E. Salgado,
• S. De la Cruz,
• J.J. Illarramendi
Published in issue: April 2021
S1
OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
• C. López Jiménez,
• C. Blanco Abad,
• J.L. Catoya Villa,
• ...
• L. Ortega Morán,
• M. Martín Jiménez,
• A. Muñoz Martín
Published in issue: April 2021
S1-S2
OC-03 Heparin treatment in COVID-19 patients is associated with reduced in-hospital mortality: findings from an observational multicenter study in Italy and a meta-analysis of 11 studies
• S. Costanzo,
• R. Parisi,
• G. de Gaetano,
• ...
• L. Iacoviello,
• A. Di Castelnuovo
• on behalf of the COVID-19 RISK and Treatments (CORIST) collaboration
Published in issue: April 2021
S2-S3

Plenary Session 1: New insights in the prevalence of cancer-associated thrombosis

OC-04 Incidence, predictors and clinical outcomes of venous thromboembolism in patients with newly diagnosed pancreatic ductal adenocarcinoma: results of the prospective BACAP-VTE study
• C. Frere,
• B. Bournet,
• S. Gourgou,
• ...
• L. Buscail,
• D. Farge
• on behalf of the Groupe Francophone Thrombose et Cancer and the BACAP Consortium
Published in issue: April 2021
S4
OC-05 Risk of venous thromboembolism in cancer patients: a cohort study
• F.I. Mulder,
• E. Horvàth-Puhó,
• N. van Es,
• ...
• L. Pedersen,
• H.R. Buller,
• H.T. Sørensen
Published in issue: April 2021
S5

Plenary Session 2: Hematologic malignancies

OC-06 The molecular mechanisms of ponatinib-induced thrombosis
• A.H. Schmaier,
• A.A. Merkulova,
• E.R. Chan,
• ...
• S.C. Mitchell,
• G.L. Forbes,
• P. Zeng
Published in issue: April 2021
S6
OC-07 Differences in thromboprophylaxis between hospitalized patients with solid or hematological malignancies
• R. Figueroa,
• M. Marcos-Jubilar,
• A. García-Mouriz,
• J.A. Páramo,
• R. Lecumberri
Published in issue: April 2021
S7

Plenary session 3: Biomarkers in CAT and cancer progression

OC-08 Biomarkers of venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis (HISPALIS study)
• R. Otero Candelera,
• V. Sánchez López,
• E. Arellano Orden,
• ...
• J.M. Sánchez Díaz,
• F.J. Rodriguez Martorell,
• P. Medina Badenes
Published in issue: April 2021
S8
OC-09 Proteomic profiling in cancer-associated VTE
• M. Panova-Noeva,
• A. Schulz,
• T. Köck,
• ...
• H. ten Cate,
• S. Heitmeier,
• P. Wild
Published in issue: April 2021
S8-S9

Plenary Session 4: Bench to bedside: new insights into hemostasis and cancer

OC-10 Thrombin tips the scales towards effective immune checkpoint blockade in cancer
• R. Cantrell,
• L. Rosenfeldt,
• D. Mureb,
• ...
• B. Monia,
• E. Janssen,
• J.S. Palumbo
Published in issue: April 2021
S10
OC-11 Plasminogen activator inhibitor 1 enhances venous thrombosis in pancreatic cancer
• Y. Hisada,
• K.B. Garratt,
• A. Maqsood,
• ...
• I. Pabinger,
• N. Mackman,
• C. Ay
Published in issue: April 2021
S10-S11

Plenary Session 5: Prevention of VTE in cancer patients

OC-12 D-dimer levels significantly decline in ambulatory cancer patients receiving rivaroxaban compared to placebo: biomarker analysis of the CASSINI trial
• S. Vadhan-Raj,
• N.M. Kuderer,
• T. Wun,
• ...
• P. Wildgoose,
• G.H. Lyman,
• A.A. Khorana
Published in issue: April 2021
S12
OC-13 A clinical-genetic risk score to predict cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
• A. Muñoz,
• C. Ay,
• E. Grilz,
• ...
• E. Salas,
• I. Pabinger,
• J.M. Soria
Published in issue: April 2021
S12-S13

Plenary Session 6: Evolving data for treatment of VTE in cancer

OC-14 Risk factors for recurrence in patients with cancer-associated venous thromboembolism: results from the Hokusai-VTE cancer study
• F.T.M. Bosch,
• T.-F. Wang,
• M. Di Nisio,
• ...
• M. Grosso,
• G. Raskob,
• N. van Es
Published in issue: April 2021
S14-S15
OC-15 Risk factors of recurrence in cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a RIETE-based prospective study
• F.X. Lapébie,
• A. Bura-Rivière,
• A. Merah,
• L. Bertoletti,
• M. Monreal
• for the RIETE investigators
Published in issue: April 2021
S15
OC-16 Apixaban as treatment for cancer-associated venous thrombosis: the CAP study
• T.L. Hannevik,
• J. Brekke,
• T. Enden,
• ...
• E.O. Velle,
• H.S. Wik,
• A.E.A. Dahm
Published in issue: April 2021
S15-S16
OC-17 Rivaroxaban vesus Dalteparin for the Treatment of Cancer- Associated Venous Thromboembolism: the CASTA DIVA Trial
• G. Meyer,
• P. Girard,
• L. Bertoletti,
• ...
• O. Sanchez,
• P. Mismetti
• on behalf the CASTA DIVA Investigators
Published in issue: April 2021
S16

POSTERS

Poster Session 1: Prevention of thrombosis

PO-01 Rivaroxaban (RX) for the prevention of venous thromboembolism (VTE) in cancer patients (CP) receiving chemotherapy (CHT)
• V.A. Sukhanov,
• O.Y. Petrova
Published in issue: April 2021
S17
PO-02 The CAT score improves targeting of thromboprophylaxis in ambulatory cancer patients in the AVERT study
• V. Kumar,
• N.S. Key,
• A. Ilich,
• ...
• R. Mallick,
• P. Wells,
• M. Carrier
Published in issue: April 2021
S17-S18
PO-03 Is extended thromboprophylaxis required for all gynaecological cancer patients post-surgery?
• F. Abu Saadeh,
• Z. Marchocki,
• S.A. O’Toole,
• N. Gleeson,
• A. Kashan,
• L.A. Norris
Published in issue: April 2021
S18
PO-04 The impact of a patient information video on patient awareness and understanding of chemotherapy induced cancer associated thrombosis
• E. Baddeley,
• N. Pease,
• A. Nelson,
• J. Sulma,
• A. Crabtree,
• S. Noble
Published in issue: April 2021
S19
PO-05 Retrospective cohort observational study of venous and arterial thrombotic event rates in POEMS patients: results from the UK-based POEMS registry and mechanistic insights
• Z. Sayar,
• A. Weatherill,
• S. Keddie,
• ...
• M.P. Lunn,
• M. Thomas,
• S. D’Sa
Published in issue: April 2021
S19
PO-06 A novel approach to venous thromboembolism thromboprophylaxis in multiple myeloma: a single-centre approach
• Z. Sayar,
• C. Gates,
• M. Thomas
Published in issue: April 2021
S19-S20
PO-07 Comparison of primary thromboprophylaxis agents (PTA) efficacy in multiple myeloma (MM) treated with immunomodulators (IMID): a network meta-analysis
• P. Haddad,
• K. Gallagher,
• D. Hammoud
Published in issue: April 2021
S20-S21
PO-08 Cancer outpatients under thromboprophylaxis: an analysis of choices and events
• J. Liz Pimenta,
• K. Ladeira,
• A. Teira,
• ...
• M. Sousa,
• M. Castelo Branco,
• M. Barbosa
Published in issue: April 2021
S21-S22
PO-09 Very high-risk patients: a prospective study of thromboembolic events in patients under thromboprophylaxis
• J. Liz Pimenta,
• K. Ladeira,
• A. Teira,
• ...
• M. Castelo Branco,
• R. Gomes,
• M. Barbosa
Published in issue: April 2021
S22

Poster Session 2: Epidemiology I

PO-10 Epidemiology of venous thromboembolism after development of second cancer
• I.L. Gade,
• M.T. Severinsen,
• K.K. Kragholm,
• S.R. Kristensen,
• C. Torp-Pedersen,
• S.J. Riddersholm
Published in issue: April 2021
S23-S24
PO-11 Venous thromboembolism in ovarian cancer patients: a nationwide Danish cohort study
• H.S. Kahr,
• O.B. Christiansen,
• S.J. Riddersholm,
• ...
• C. Torp-Pedersen,
• A. Knudsen,
• O. Thorlacius-Ussing
Published in issue: April 2021
S24
PO-12 Statins and risk of cancer in patients with venous thromboembolism: a Danish population-based cohort study
• N. Skajaa,
• D. Nagy,
• F.S. Troelsen,
• D.K. Farkas,
• H.T. Sørensen
Published in issue: April 2021
S24
PO-13 Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study (STAC)
• M.J.T. Crobach,
• R.J.S. Anijs,
• S.K. Brækkan,
• ...
• J. Hansen,
• I.A. Næss,
• S.C. Cannegieter
Published in issue: April 2021
S24-S25
PO-14 Venous thromboembolism and risk of cancer in women treated with postmenopausal hormone replacement: a Danish population-based cohort study
• L.S. Svingel,
• D. Nagy,
• F.S. Troelsen,
• D.K. Farkas,
• H.T. Sørensen
Published in issue: April 2021
S25
PO-15 Venous thromboembolism may be a marker of occult cancer in patients with kidney disease
• A.D. Kjaergaard,
• D. Nagy,
• C.F. Christiansen,
• F.S. Troelsen,
• K. Farkas,
• H.T. Sørensen
Published in issue: April 2021
S25
PO-16 Venous thromboembolism in small cell lung cancer patients: an epidemiological study
• E. Dimakakos,
• K. Livanios,
• E. Kainis,
• ...
• E. Kotteas,
• G.T. Gerotziafas,
• K. Syrigos
Published in issue: April 2021
S25-S26
PO-17 Mesothelioma: a retrospective study of thromboembolism events
• E. Dimakakos,
• K. Basdeki,
• I. Gkiozos,
• ...
• I. Trontzas,
• E. Kotteas,
• K. Syrigos
Published in issue: April 2021
S26
PO-18 Venous thromboembolism and risk of cancer in patients with dementia: a Danish population-based cohort study
• C.H. Fuglsang,
• D. Nagy,
• F.S. Troelsen,
• D.K. Farkas,
• V.W. Henderson,
• H.T. Sørensen
Published in issue: April 2021
S26
PO-19 Initiation of low-dose aspirin and risk of colorectal neoplasms: a population-based matched cohort study in Denmark
• E. Schønfeldt Troelsen,
• D. Körmendiné Farkas,
• R. Erichsen,
• T. Sørensen
Published in issue: April 2021
S26
PO-20 Incidence of venous thromboembolism in men with prostate cancer and men without prostate cancer: a nationwide population-based cohort study in Sweden
• B. Farahmand,
• Y. Balabanova,
• P. Stattin,
• H. Garmo,
• G. Brobert
Published in issue: April 2021
S27
PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19.
• A. Gutiérrez Ortiz de la Tabla,
• D.S. Juliao Caamaño,
• C. López Jiménez,
• ...
• L. Ortega Morán,
• M. Martín,
• A. Muñoz Martín
Published in issue: April 2021
S27-S28
PO-22 Venous thromboembolism in cancer patients – data from Regional Centre for transfusion medicine Shtip
• M. Shorova
Published in issue: April 2021
S28-S29

Poster Session 3: Hypercoagulability in cancer

PO-23 Hypercoagulabilty in upper gastrointestinal cancer patients: a longitudinal study
• A.C. Larsen,
• J. Brøndum Frøkjær,
• R.V. Fisker,
• M. Yilmaz,
• S.R. Kristensen,
• O. Thorlacius-Ussing
Published in issue: April 2021
S30
PO-24 Lung cancer: the clinical profile of D-dimers
• E. Kokkotou,
• I. Gkiozos,
• D. Vassos,
• ...
• G.T. Gerotziafas,
• K. Syrigos,
• E. Dimakakos
Published in issue: April 2021
S30
PO-25 Plasma levels of activated factor VII–antithrombin complex predict mortality in subjects with liver and colon cancer undergoing curative surgical intervention
• N. Martinelli,
• S. Moruzzi,
• A. Castagna,
• ...
• F. Bernardi,
• O. Olivieri,
• S. Friso
Published in issue: April 2021
S30-S31
PO-26 Fibrinogen levels and risk of colorectal cancer in a case–cohort study from the Italian general adult population: results from the Moli-sani study
• S. Costanzo,
• A. De Curtis,
• A. Di Castelnuovo,
• ...
• M.B. Donati,
• L. Iacoviello
• on behalf of the Moli-sani Study Investigators
Published in issue: April 2021
S31
PO-27 Tissue plasminogen activator and risk of breast cancer in a cas–cohort study from Italian women of a general population: results from the Moli-sani study
• S. Costanzo,
• A. De Curtis,
• A. Di Castelnuovo,
• ...
• M.B. Donati,
• L. Iacoviello
• on behalf of the Moli-sani Study Investigators
Published in issue: April 2021
S31-S32
PO-28 Circulating markers of neutrophil activation and nets, but not of coagulation and fibrinolysis, predict mortality in patients with terminal cancer
• A. Rosell,
• K. Aguilera,
• M. Daleskog,
• ...
• S. Lundström,
• H. Wallén,
• C. Thålin
Published in issue: April 2021
S32
PO-29 Plasma levels of procoagulant and anticoagulant factors in patients with acute cancer-associated thrombosis
• E. Campello,
• L. Spiezia,
• C. Simion,
• ...
• M. Fadin,
• S. Gavasso,
• P. Simioni
Published in issue: April 2021
S32
PO-30 Inherited deficiency of antithrombin, protein C or protein S is associated with an increased risk of cancer at a younger age
• D. Tormene,
• S. Gavasso,
• G. Turatti,
• ...
• M. Marobin,
• E. Campello,
• P. Simioni
Published in issue: April 2021
S32-S33